Blue Crest Capital Management LTD Abbott Laboratories Put Options Transaction History

Blue Crest Capital Management LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $4.65 Million - $5.14 Million	-42,500 Reduced 60.37%	27,900 $3.17 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.98 Million - $2.43 Million	22,000 Added 45.45%	70,400 $7.75 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.53 Million - $4.24 Million	37,000 Added 324.56%	48,400 $4.69 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.15 Million - $1.28 Million	11,400 New	11,400 $1.24 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $7.98 Million - $9.73 Million	-70,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $8.09 Million - $9.9 Million	70,000 New	70,000 $9.85 Million

3,161

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.